IAVI and its partners are advancing a diverse porfolio of select preventive HIV vaccine candidates.
IAVI details its organizational strategic vision for the period 2011-2015 made.
Engage with IAVI on your social media networks.
IAVI's R&D team designs and develops HIV vaccine candidates and conducts vaccine trials and related epidemiological research in partnership with researchers across the globe.
Researchers have made encouraging progress recently toward the development of an HIV vaccine.
IAVI works with partners to advocate for the development of preventive AIDS vaccines as an essential component of a comprehensive response to the HIV pandemic.
The HIV Vaccines and Microbicides Resource Tracking Working Group monitors funding trends in HIV vaccine R&D.
IAVI collaborates with more than 50 academic, industry and government organizations around the world to research and develop AIDS vaccines and to advocate for the field.
Community Advisory Boards play an important role in HIV prevention research.
International AIDS Vaccine Initiative. All rights reserved. International AIDS Vaccine Initiative, IAVI and the IAVI logo are trademarks of the International AIDS Vaccine Initiative, Inc.